Literature DB >> 12085030

Pancreatic stent placement for duct disruption.

Jennifer J Telford1, James J Farrell, John R Saltzman, Steven J Shields, Peter A Banks, David R Lichtenstein, Richard S Johannes, Peter B Kelsey, David L Carr-Locke.   

Abstract

BACKGROUND: The aim of this study was to identify predictors of outcome after pancreatic duct stent placement for duct disruption.
METHODS: Patients were identified from endoscopy databases. Disruption was defined by extravasation of contrast from the pancreatic duct during endoscopic retrograde pancreatography. Data collected included demographic information, imaging studies, management before and outcome after stent placement. Success was defined as resolution of the disruption clinically, on radiologic imaging, and/or at endoscopic retrograde pancreatography.
RESULTS: Forty-three patients (23 women, 20 men; mean age 57 years, [SD] 15.2 years) were studied. The etiology of pancreatic duct disruption was acute pancreatitis in 24, chronic pancreatitis in 9, operative injury in 7, and trauma in 3 patients. In 25 patients there was resolution of the disruption, whereas stent therapy was unsuccessful in 16 and the outcome was indeterminate in 2 patients. On univariate analysis, stent positioned to bridge the disruption (p = 0.04) and longer duration of stent therapy (p = 0.002) were associated with a successful outcome. Female gender (p = 0.05) and acute pancreatitis (p = 0.05) were associated with a lack of success. On multivariate analysis, only the bridging stent position remained correlated to outcome. Complications occurred in 4 patients.
CONCLUSIONS: A bridging stent is associated with a successful outcome after pancreatic duct stent placement for duct disruption.

Entities:  

Mesh:

Year:  2002        PMID: 12085030     DOI: 10.1067/mge.2002.125107

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  40 in total

Review 1.  Endoscopic papillotomy, syn. sphincterotomy: results from the past two years.

Authors:  Meinhard Classen; Peter Born
Journal:  Curr Gastroenterol Rep       Date:  2004-04

2.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

3.  Non-operative management of pancreatic pseudocysts: there is still a role.

Authors:  Shyam Varadarajulu
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  Endoscopic naso-pancreatic drainage for the treatment of pancreatic fistula occurring after LDLT.

Authors:  Akihisa Nagatsu; Masahiko Taniguchi; Tsuyoshi Shimamura; Tomomi Suzuki; Kenichiro Yamashita; Hiroshi Kawakami; Daisuke Abo; Toshiya Kamiyama; Hiroyuki Furukawa; Satoru Todo
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 5.  Endotherapy in chronic pancreatitis.

Authors:  Manu Tandan; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

6.  The value of endoscopic diagnosis and the treatment of pancreas injuries following blunt abdominal trauma.

Authors:  A Wolf; J Bernhardt; M Patrzyk; C-D Heidecke
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

7.  Outcome of pancreatic ascites in patients with tropical calcific pancreatitis managed using a uniform treatment protocol.

Authors:  Prakash Kurumboor; Deepak Varma; Mahendra Rajan; Naduthottam Palanisami Kamlesh; Roshin Paulose; Ramesh Ganesh Narayanan; Mathew Philip
Journal:  Indian J Gastroenterol       Date:  2009-11-12

8.  [Isolated pancreatic trauma: report of 5 cases].

Authors:  Hicham El Bouhaddouti; Abdelmalek Ousadden; Karim Ibn Majdoub Hassani; Amal Ankouz; Abdesslam Bouassria; Abdellatif Louchi; Khalid Mazaz; Khalid Ait Taleb
Journal:  Pan Afr Med J       Date:  2010-03-15

Review 9.  Endoscopic therapy for chronic pancreatitis: technical success, clinical outcomes, and complications.

Authors:  Lukasz M Kowalczyk; Peter V Draganov
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 10.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.